Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: A systematic review and meta-analysis

Journal of the American College of Cardiology

Volumn 62, Issue 9, 2013, Pages 826-838

  Lipinski, Michael J ^a   McVey, Courtney M ^a   Berger, Jeffrey S ^b   Kramer, Christopher M ^a   Salerno, Michael ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

late gadolinium enhancement; myocardial perfusion; prognosis; stress cardiac MRI

Indexed keywords

DOBUTAMINE; GADOLINIUM; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STRESS CARDIAC MAGNETIC RESONANCE IMAGING; SYSTEMATIC REVIEW;

AER; ANNUALIZED EVENT RATE; CAD; CARDIAC MAGNETIC RESONANCE IMAGING; CMR; CORONARY ARTERY DISEASE; LATE GADOLINIUM ENHANCEMENT; LGE; MACE; MAJOR ADVERSE CARDIOVASCULAR EVENT(S); MI; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION; ODDS RATIO; OR; PROGNOSIS; STRESS CARDIAC MRI;

AGED; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT;

EID: 84882777741     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.080     Document Type: Article

References (63)

1. K.R. Nandalur, B.A. Dwamena, A.F. Choudhri, M.R. Nandalur, and R.C. Carlos Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis J Am Coll Cardiol 50 2007 1343 1353
2. M. Hamon, G. Fau, G. Nee, J. Ehtisham, and R. Morello Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease J Cardiovasc Magn Reson 12 2010 29
3. J. Schwitter, C.M. Wacker, and N. Wilke MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial Eur Heart J 34 2013 775 781
4. J.P. Greenwood, N. Maredia, and J.F. Younger Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial Lancet 379 2012 453 460
5. V. Bodi, J. Sanchis, and J. Nunez Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction J Am Coll Cardiol Img 2 2009 835 842
6. O. Bruder, F. Breuckmann, and C. Jensen Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen." Herz 33 2008 136 142
7. K.C. Wu, R.G. Weiss, and D.R. Thiemann Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421
8. M. Tsukiji, P. Nguyen, and G. Narayan Peri-infarct ischemia determined by cardiovascular magnetic resonance evaluation of myocardial viability and stress perfusion predicts future cardiovascular events in patients with severe ischemic cardiomyopathy J Cardiovasc Magn Reson 8 2006 773 779
9. W.G. Hundley The use of cardiovascular magnetic resonance to identify adverse cardiac prognosis: an important step in reducing image-related heath care expenditures J Am Coll Cardiol 56 2010 1244 1246
10. A. Chiribiri, N. Bettencourt, and E. Nagel Cardiac magnetic resonance stress testing: results and prognosis Curr Cardiol Rep 11 2009 54 60
11. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
12. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269 W64
13. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed December 30, 2012.
14. J.A. Sterne, and M. Egger Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis J Clin Epidemiol 54 2001 1046 1055
15. J.L. Peters, A.J. Sutton, D.R. Jones, K.R. Abrams, and L. Rushton Comparison of two methods to detect publication bias in meta-analysis JAMA 295 2006 676 680
16. J.M. Bland, and S.M. Kerry Statistics notes. Weighted comparison of means BMJ 316 1998 129
17. V. Bodi, J. Sanchis, and M.P. Lopez-Lereu Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease J Am Coll Cardiol 50 2007 1174 1179
18. V. Bodi, J. Sanchis, and M.P. Lopez-Lereu Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade Heart 95 2009 49 55
19. E. Dall'Armellina, T.M. Morgan, and S. Mandapaka Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index J Am Coll Cardiol 52 2008 279 286
20. S. de Waha, S. Desch, and I. Eitel Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers Eur Heart J 31 2010 2660 2668
21. S. de Waha, S. Desch, and I. Eitel Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging Clin Res Cardiol 101 2012 487 495
22. M. Doyle, N. Weinberg, and G.M. Pohost Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study J Am Coll Cardiol Img 3 2010 1030 1036
23. G. Hartlage, M. Janik, and A. Anadiotis Prognostic value of adenosine stress cardiovascular magnetic resonance and dobutamine stress echocardiography in patients with low-risk chest pain Int J Cardiovasc Imaging 28 2012 803 812
24. V. Hombach, O. Grebe, and N. Merkle Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging Eur Heart J 26 2005 549 557
25. W.G. Hundley, T.M. Morgan, C.M. Neagle, C.A. Hamilton, P. Rerkpattanapipat, and K.M. Link Magnetic resonance imaging determination of cardiac prognosis Circulation 106 2002 2328 2333
26. O. Husser, V. Bodi, and J. Sanchis Head to head comparison of quantitative versus visual analysis of contrast CMR in the setting of myocardial stunning after STEMI: implications on late systolic function and patient outcome Int J Cardiovasc Imaging 26 2010 559 569
27. C. Jahnke, E. Nagel, and R. Gebker Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging Circulation 115 2007 1769 1776
28. A. Johansen, P.F. Hoilund-Carlsen, W. Vach, H.W. Christensen, M. Moldrup, and T. Haghfelt Prognostic value of myocardial perfusion imaging in patients with known or suspected stable angina pectoris: evaluation in a setting in which myocardial perfusion imaging did not influence the choice of treatment Clin Physiol Funct Imaging 26 2006 288 295
29. S. Kelle, C. Egnell, and J. Vierecke Prognostic value of negative dobutamine-stress cardiac magnetic resonance imaging Med Sci Monit 15 2009 MT131 MT136
30. G. Korosoglou, A. Haars, and G. Michael Quantitative evaluation of myocardial blush to assess tissue level reperfusion in patients with acute ST-elevation myocardial infarction: incremental prognostic value compared with visual assessment Am Heart J 153 2007 612 620
31. G. Korosoglou, G. Gitsioudis, and A. Voss Strain-encoded cardiac magnetic resonance during high-dose dobutamine stress testing for the estimation of cardiac outcomes: comparison to clinical parameters and conventional wall motion readings J Am Coll Cardiol 58 2011 1140 1149
32. R.Y. Kwong, A.K. Chan, and K.A. Brown Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743
33. G. Pilz, S. Eierle, and T. Heer Negative predictive value of normal adenosine-stress cardiac MRI in the assessment of coronary artery disease and correlation with semiquantitative perfusion analysis J Magn Reson Imaging 32 2010 615 621
34. E.L. Wallace, T.M. Morgan, and T.F. Walsh Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease J Am Coll Cardiol Img 2 2009 299 307
35. T.F. Walsh, E. Dall'Armellina, and H. Chughtai Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress J Cardiovasc Magn Reson 11 2009 25
36. K.C. Wu, E.A. Zerhouni, and R.M. Judd Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772
37. E. Wu, J.T. Ortiz, and P. Tejedor Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study Heart 94 2008 730 736
38. A.G. Bertaso, J.D. Richardson, and D.T. Wong Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population Int J Cardiol 2012 Jun 2 [E-pub ahead of print]
39. S.E. Bingham, and R. Hachamovitch Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress perfusion, delayed enhancement, and left ventricular function over preimaging information for the prediction of adverse events Circulation 123 2011 1509 1518
40. V. Bodi, O. Husser, and J. Sanchis Prognostic implications of dipyridamole cardiac MR imaging: a prospective multicenter registry Radiology 262 2012 91 100
41. D. Buckert, P. Dewes, T. Walcher, W. Rottbauer, and P. Bernhardt Intermediate-term prognostic value of reversible perfusion deficit diagnosed by adenosine CMR: A prospective follow-up study in a consecutive patient population J Am Coll Cardiol Img 6 2013 56 63
42. O.R. Coelho-Filho, L.F. Seabra, and F.P. Mongeon Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex J Am Coll Cardiol Img 4 2011 850 861
43. C. Doesch, A. Seeger, and J. Doering Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity J Am Coll Cardiol Img 2 2009 424 433
44. W.P. Ingkanisorn, R.Y. Kwong, and N.S. Bohme Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain J Am Coll Cardiol 47 2006 1427 1432
45. C. Jahnke, V. Furundzija, and R. Gebker Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging Int J Cardiovasc Imaging 28 2011 1087 1098
46. R. Krittayaphong, V. Chaithiraphan, A. Maneesai, and S. Udompanturak Prognostic value of combined magnetic resonance myocardial perfusion imaging and late gadolinium enhancement Int J Cardiovasc Imaging 27 2011 705 714
47. S. Lerakis, D.S. McLean, and A.V. Anadiotis Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain J Cardiovasc Magn Reson 11 2009 37
48. K.Y. Lo, K.F. Leung, C.M. Chu, K.L. Loke, C.K. Chan, and C.S. Yue Prognostic value of adenosine stress myocardial perfusion by cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease QJM 104 2011 425 432
49. D.D. Lubbers, D. Rijlaarsdam-Hermsen, and D. Kuijpers Performance of adenosine "stress-only" perfusion MRI in patients without a history of myocardial infarction: a clinical outcome study Int J Cardiovasc Imaging 28 2012 109 115
50. G. Pilz, A. Jeske, and M. Klos Prognostic value of normal adenosine-stress cardiac magnetic resonance imaging Am J Cardiol 101 2008 1408 1412
51. K. Steel, R. Broderick, and V. Gandla Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease Circulation 120 2009 1390 1400
52. J. Vogel-Claussen, J. Skrok, and D. Dombroski Comprehensive adenosine stress perfusion MRI defines the etiology of chest pain in the emergency room: comparison with nuclear stress test J Magn Reson Imaging 30 2009 753 762
53. C. Charoenpanichkit, T.M. Morgan, and C.A. Hamilton Left ventricular hypertrophy influences cardiac prognosis in patients undergoing dobutamine cardiac stress testing Circ Cardiovasc Imaging 3 2010 392 397
54. R. Gebker, C. Jahnke, and R. Manka The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease J Cardiovasc Magn Reson 13 2011 46
55. S. Kelle, A. Chiribiri, and J. Vierecke Long-term prognostic value of dobutamine stress CMR J Am Coll Cardiol Img 4 2011 161 172
56. G. Korosoglou, Y. Elhmidi, and H. Steen Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion J Am Coll Cardiol 56 2010 1225 1234
57. S.M. Navare, J.F. Mather, L.J. Shaw, M.S. Fowler, and G.V. Heller Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis J Nucl Cardiol 11 2004 551 561
58. L.D. Metz, M. Beattie, R. Hom, R.F. Redberg, D. Grady, and K.E. Fleischmann The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis J Am Coll Cardiol 49 2007 227 237
59. H. Makani, S. Bangalore, D. Halpern, H.G. Makwana, and F.A. Chaudhry Cardiac outcomes with submaximal normal stress echocardiography: a meta-analysis J Am Coll Cardiol 60 2012 1393 1401
60. L.J. Shaw, R. Hendel, and S. Borges-Neto Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients J Nucl Med 44 2003 134 139
61. B.J. Chow, G. Small, and Y. Yam Incremental prognostic value of cardiac computed tomography in coronary artery disease using CONFIRM: COroNary computed tomography angiography evaluation for clinical outcomes: an InteRnational Multicenter registry Circ Cardiovasc Imaging 4 2011 463 472
62. S.V. Raman, J.A. Dickerson, and M. Jekic Real-time cine and myocardial perfusion with treadmill exercise stress cardiovascular magnetic resonance in patients referred for stress SPECT J Cardiovasc Magn Reson 12 2010 41
63. A. Wagner, O. Bruder, and S. Schneider Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry J Cardiovasc Magn Reson 11 2009 43